1Bastard JP,Pieroni L,Hainque B.Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance.Diabetes Metab Res Rev,2000,16:192-201.
2Pandolfi A,Giaccari A,Cilli C,et al.Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat.Acta Diabetol,2001,38:71-76.
3Samad F,Pandey M,Bell PA,et al.Insulin continues to induce plasminogen activator inhibitor 1 gene expression in insulin- resistant mice and adipocytes.Mol Med,2000,6:680-692.
4Seli E,Duleba A J.Should patients with polycystic ovarian syndrome be treated with metformin.Hum Reprod,2002,17:2230-2236.
5Zuccollo A,Navarro M,Frontera M,et al.The involvement of kallikrein-kinin system in diabetes type Ⅰ (insulitis).Immunopharmacol,1999,45:69-74.
6Vambergue A,Rugeri L,Gaveriaux V,et al.Factor Ⅶ,tissue factor pathway inhibitor,and monocyte tissue factor in diabetes mellitus: influence of type of diabetes,obesity index,and age.Thromb Res,2001,101:367-375.
7Chadarevian R,Bruckert E,Dejager S,et al.Relationship between triglycerides and factor Ⅶc and plasminogen activator inhibitor type-1:lack of threshold value. Thromb Res,1999,96:175-182.
8Davi G,Ciabattoni G,Consoli A,et al.In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.Circulation,1999,99:224-229.
9Limb GA,Webster L,Soomro H,et al.Platelet expression of tumour necrosis factor-alpha (TNF-alpha),TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy.Clin Exp Immunol,1999,118:213-218.
10Hadigan C,Meigs JB,Rabe J,et al.Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance.J Clin Endocrinol Metab,2001,86:939-943.
